 |
 |
 |
|---|
AAB/NILA/CRB CORONAVIRUS Resource & News Center
AAB/NILA/CRB Comments, Position Statements, Letters
1/15/21 - NILA Supports President-Elect Biden's Plans to Expand and Improve COVID-19 Testing Supplies
12/21/20 - NILA Comments on CMS Rules for Posting COVID-19 Pricing Data
Regulatory Resources
CDC
- Clinical Laboratory COVID-19 Response Calls
- COVID-19 Resource Center
- Diagnostic Tools and Virus
- Frequently Asked Questions (FAQ)
- Information for Laboratories about COVID-19
- Interim Guidance for Antigen Testing for SARS-CoV-2
- Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19
- Laboratory Outreach Communication System (LOCS)
- LOINC In Vitro Diagnostic (LIVD) Test Code Mapping for SARS-CoV-2 Tests
CMS
FDA
Association Resources
AAB Webinar Recordings
- Part 1: COVID-19 Virology And Infections (Members Only)
- Part 2: COVID-19 Antibody Testing And Test Performance Data (Members Only)
- Part 3: COVID-19 Transmission Through The Environment And Tracking Down Cases Based On Wastewater Epidemiology (Members Only)
- Part 4: COVID-19 Host Immunogenetics And Innate Immunity (Members Only)
